MARLBORO | Jotup

Loeb Leadership Welcomes New Associate Consulting Practice Group Leader Tamara Fox

Retrieved on:

星期三, 三月 22, 2023

Human Capital Institute, Human resources, Bachelor, University of Colorado Denver School of Public Affairs, University, Fox, Culture, Workplace, Tamara, Human, Consultant, Organization, Business administration, Professional in Human Resources, PHR, Growth, Bestie Tamara Atti, CEP, Management

NEW YORK, March 22, 2023 /PRNewswire/ -- Loeb Leadership, a global leadership development firm, is pleased to welcome Tamara Fox as the new Associate Practice Group Leader of Loeb Leadership's consulting branch.

Key Points:

NEW YORK, March 22, 2023 /PRNewswire/ -- Loeb Leadership, a global leadership development firm, is pleased to welcome Tamara Fox as the new Associate Practice Group Leader of Loeb Leadership's consulting branch.
Fox is a highly experienced leadership development and culture consultant with over 10 years of experience in Human Resources and Human Resources consulting.
Fox will work closely with Loeb Leadership's senior leadership team, including her predecessor David Robert, who now serves as the company's Co-CEO, Founder and Co-CEO Natalie Loeb, and President Gordon Loeb.
As the Consulting Practice Group Leader, Tamara will be responsible for leading and managing Loeb Leadership's culture consulting and organizational development services.

Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

Retrieved on:

星期二, 三月 7, 2023

Food and Drug Administration Safety and Innovation Act, ReWalk, Rehabilitation, Walking, FDA, CE, Safety, Guinness, Medicare, Robotics, Life, Food, Medical device

The clearance follows the FDA’s designation of the device as a "Breakthrough Device" in recognition of its unprecedented ability to provide ambulatory access to environments containing stairs and curbs for paralyzed individuals with spinal cord injury (“SCI”).

Key Points:

The clearance follows the FDA’s designation of the device as a "Breakthrough Device" in recognition of its unprecedented ability to provide ambulatory access to environments containing stairs and curbs for paralyzed individuals with spinal cord injury (“SCI”).
“I’m in full control of the exoskeleton, and I am able to conquer stairs and other obstacles that may appear in my way.
It’s been life-changing for me.”
ReWalk looks forward to expanding the possibilities for its users in the United States with this recent FDA clearance.
For more information on the ReWalk systems, please visit rewalk.com .

ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on:

星期四, 二月 23, 2023

European, General Administration of Press and Publication, COVID, Insurance, Share repurchase, Travel, MAC, Research and development, CMS, Medicare, ReWalk, EST, Centers for Medicare & Medicaid Services, Administration, Rehabilitation, Video game, Pharmaceutical industry

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three months and full year ended December 31, 2022.

Key Points:

Operating expenses in the fourth quarter of 2022 were $5.7 million, an increase of $1.5 million, or 37%, as compared to $4.2 million in the fourth quarter of 2021.
Net loss for the fourth quarter of 2022 was $5.3 million, compared to a net loss of $3.9 million in the fourth quarter of 2021.
Non-GAAP net loss for the fourth quarter of 2022 was $4.9 million compared to $3.6 million in the fourth quarter of 2021.
ReWalk management will host a conference call and live webcast at 8:30 a.m. EST today to discuss the financial results.

ReWalk Robotics to Report Fourth Quarter and Fiscal Year-End 2022 Financial Results on February 23, 2023

Retrieved on:

星期四, 二月 16, 2023

Rare-earth element, Management, Drug

MARLBOROUGH, Mass.

Key Points:

MARLBOROUGH, Mass.
and BERLIN and YOKNEAM ILIT, Israel, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2022 financial results on Thursday, February 23, 2023, at 8:30 AM Eastern time.
Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows:

Loeb Leadership Announces David Robert as New Co-CEO and Plans for Rapid Growth of Its Workplace Culture Consulting Practice

Retrieved on:

星期二, 一月 17, 2023

Organization, DE, General Electric, Consultant, Great Places, Growth, Johnson & Wales University, Cornell University, FedEx, Microsoft, Blue Cross, MBA, Impact, Blue Shield, PepsiCo, DHL, Management

Robert has been a part of Loeb Leadership's executive team since 2018, first as Chief Talent Strategist, then as Chief Operating Officer.

Key Points:

Robert has been a part of Loeb Leadership's executive team since 2018, first as Chief Talent Strategist, then as Chief Operating Officer.
Robert brings over twenty years of experience in the areas of leadership, organizational development, change management, and workplace culture.
Loeb Leadership continues to expand rapidly and expects significant growth in 2023, particularly in its organizational development and culture consulting practices.
Loeb Leadership is based in Marlboro, NJ, and with over eighty coaches, facilitators, and consultants, offers services and training all over the world.

“Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp

Retrieved on:

星期四, 一月 5, 2023

ReWalk, Diplomatic mission, Robotics, SCI, Creativity, Walking, Hanukkah, Health, Ambassador, Interview, Flanders, Quality of life, Life

“ReWalk represents a great example of Israeli technology where we have expertise in sectors such as cyber protection, water management, energy solutions, and healthcare.

Key Points:

“ReWalk represents a great example of Israeli technology where we have expertise in sectors such as cyber protection, water management, energy solutions, and healthcare.
Another individual in attendance at the event was Jitse van Thilo, who recently became the second ReWalker in Belgium.
“We are pleased to have demonstrated our technology at this prestigious event hosted by the Embassy of the State of Israel in Belgium to increase awareness of the benefits of ReWalk and expand access to our technology.
For more information on ReWalk Robotics and the ReWalk exoskeleton, visit rewalk.com .

ReWalk Announces Extension of Share Repurchase Program

Retrieved on:

星期四, 十二月 22, 2022

ReWalk, COVID-19, Share repurchase, Movement, NIS, CMS, Pharmaceutical industry, Risk management

The Company’s ongoing $8.0 million repurchase program was previously approved by the Board and an Israeli court for a six month period ending on January 20, 2023.

Key Points:

The Company’s ongoing $8.0 million repurchase program was previously approved by the Board and an Israeli court for a six month period ending on January 20, 2023.
The Board’s approval of the $5.8 million repurchase program extension is intended to facilitate purchases of up to an aggregate of $8.0 million of its Ordinary Shares over the life of the repurchase program, as extended.
The Board believes that extension of the share repurchase program at this time is in the best interests of the Company and its shareholders, and will not impact ReWalk’s ability to execute its growth plans.
The repurchase program does not require ReWalk to acquire a specific number of shares, and may be suspended or discontinued at any time.

Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation

Retrieved on:

星期五, 十一月 11, 2022

MARLBOROUGH, Mass. and BERLIN, Nov. 11, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), today welcomed the decision by BARMER to accept the prior ruling from the state court that exoskeletons are considered as direct disability compensation and withdraw the pending case at the federal level shortly before the hearing. This outcome means that an eligible insured person with spinal cord injury (SCI) has a legal basis for the supply of an exoskeleton as an orthopedic aid for direct disability compensation in Germany, ReWalk’s largest market for exoskeletons.

Key Points:

This outcome means that an eligible insured person with spinal cord injury (SCI) has a legal basis for the supply of an exoskeleton as an orthopedic aid for direct disability compensation in Germany, ReWalks largest market for exoskeletons.
The definition of direct disability compensation applies to medical aids which replace failed and impaired bodily functions to the extent that the person using them is on par with people without disabilities.
The successful conclusion of this legal dispute identifying the exoskeleton as direct disability compensation changes the landscape for the eligible paralyzed community, stated Larry Jasinski, CEO of ReWalk.
The German healthcare system has led the way in its adoption of exoskeletons for spinal cord injured individuals.

ReWalk Robotics Reports Third Quarter 2022 Financial Results

Retrieved on:

星期一, 十一月 7, 2022

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced its financial results for the three and nine months ended September 30, 2022.

Key Points:

ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

Retrieved on:

星期一, 十月 31, 2022

Stroke, Quality of life, ReWalk, Computer data storage

Please request to be connected to ReWalk Robotics Ltd. call

Key Points:

Please request to be connected to ReWalk Robotics Ltd. call
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.
ReWalks mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany.
ReWalk is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.